Medicare Enrolled
Dr. Edward Flores, M.D.
Pulmonary Disease · Conroe, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Flores from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Flores?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Flores
Dr. Edward Flores is a pulmonary disease specialist in Conroe, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Flores performed 3,912 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Flores received a total of $4,236 from 36 pharmaceutical and/or device companies across 246 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Flores is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in TX
$4,236 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,912
Medicare services
Top 7% in TX for pulmonary disease
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
905 | $87 | $270 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
416 | $37 | $165 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
413 | $37 | $161 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
326 | $13 | $59 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
262 | $27 | $184 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
211 | $31 | $158 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
207 | $23 | $93 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $58 | $183 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
191 | $24 | $105 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
170 | $19 | $109 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
124 | $92 | $387 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
99 | $8 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $113 | $416 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
45 | $91 | $372 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $82 | $271 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
30 | $35 | $110 |
| Liver function blood test panel | 29 | $8 | $33 |
| Rheumatoid factor analysis | 21 | $6 | $23 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
19 | $4 | $15 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
19 | $5 | $21 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $62 | $183 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
16 | $8 | $32 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
16 | $57 | $220 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
14 | $32 | $187 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $31 | $76 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $31 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,236
Total received (2018-2024)
Avg $605/year across 7 years
Top 37% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
246
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,401
2023
$854
2022
$666
2021
$846
2020
$114
2019
$250
2018
$104
Payments by company (2024)
GlaxoSmithKline, LLC.
$418
AstraZeneca Pharmaceuticals LP
$329
Philips North America LLC
$99
United Therapeutics Corporation
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Grifols USA, LLC
$65
PFIZER INC.
$52
ANI Pharmaceuticals, Inc.
$40
Regeneron Healthcare Solutions, Inc.
$33
Insmed, Inc.
$32
LEO Pharma Inc.
$30
GENZYME CORPORATION
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
Vifor Pharma, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
HARMONY BIOSCIENCES LLC
$21
Baxter Healthcare
$17
Lilly USA, LLC
$15
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,206
AstraZeneca Pharmaceuticals LP
$1,049
Insmed, Inc.
$211
Regeneron Healthcare Solutions, Inc.
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
Philips Electronics North America Corporation
$128
Mallinckrodt Hospital Products Inc.
$124
United Therapeutics Corporation
$110
Janssen Pharmaceuticals, Inc
$110
Philips North America LLC
$99
GENZYME CORPORATION
$89
Grifols USA, LLC
$85
Sunovion Pharmaceuticals Inc.
$71
PFIZER INC.
$69
Bayer Healthcare Pharmaceuticals Inc.
$68
Genentech USA, Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
ANI Pharmaceuticals, Inc.
$40
Electromed, Inc.
$39
Baxter Healthcare
$36
Actelion Pharmaceuticals US, Inc.
$30
LEO Pharma Inc.
$30
Amgen Inc.
$29
Merck Sharp & Dohme LLC
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Allergan Inc.
$24
Vifor Pharma, Inc.
$22
HARMONY BIOSCIENCES LLC
$21
ADVANCED RESPIRATORY, INC
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Lilly USA, LLC
$15
Otsuka America Pharmaceutical, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Mylan Specialty L.P.
$12
Inogen, Inc.
$8
Top 3 companies account for 58.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADBRY · AIRSUPRA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · DUPIXENT · ELIQUIS · EVENITY · Enbrel · Esbriet · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · InogenOne · Kerendia · LIBTAYO · LONHALA MAGNAIR · MOUNJARO · NUCALA · OFEV · OPSUMIT · ORENITRAM · PAXLOVID · PNEUMOVAX 23 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · REMODULIN · REXULTI · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Monarch Airway Clearance System · WAKIX · Wellcentive Undiv · XARELTO · XIFAXAN · ZERBAXA · Zemaira · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
17
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Flores is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Flores experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Flores performed 905 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Flores receive payments from pharmaceutical companies?
Yes. Dr. Flores received a total of $4,236 from 36 companies across 246 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Flores's costs compare to other pulmonary diseases in Conroe?
Dr. Flores's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Flores) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Conroe
Browse pulmonary diseases in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology